| __timestamp | Regeneron Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 205018000 | 179279000 |
| Thursday, January 1, 2015 | 392709000 | 186359000 |
| Friday, January 1, 2016 | 299694000 | 171785000 |
| Sunday, January 1, 2017 | 397061000 | 208136000 |
| Monday, January 1, 2018 | 434100000 | 198405000 |
| Tuesday, January 1, 2019 | 782200000 | 224169000 |
| Wednesday, January 1, 2020 | 1119900000 | 245044000 |
| Friday, January 1, 2021 | 2437500000 | 252314000 |
| Saturday, January 1, 2022 | 1560400000 | 268225000 |
| Sunday, January 1, 2023 | 1815800000 | 304629000 |
| Monday, January 1, 2024 | 1970500000 | 324203000 |
Unleashing insights
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Regeneron Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, Regeneron has seen a dramatic increase in its cost of revenue, peaking in 2021 with a staggering 1,100% rise from its 2014 figures. In contrast, Taro's cost of revenue has remained relatively stable, with a modest 80% increase over the same period.
Regeneron's aggressive growth strategy is evident, but it comes with higher costs. Meanwhile, Taro's steady approach reflects a more conservative financial management style. The data for 2024 is incomplete, highlighting the need for ongoing analysis. This comparison underscores the diverse strategies within the pharmaceutical industry and their impact on financial efficiency.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Regeneron Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Comparing Cost of Revenue Efficiency: Ligand Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.